{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "discontinued_date": "09/19/2025",
      "update_type": "New",
      "initial_posting_date": "09/19/2025",
      "package_ndc": "69516-005-30",
      "generic_name": "Obeticholic Acid Tablet",
      "contact_info": "1-844-782-4278",
      "related_info": "Business decision. Products will not be available after November 14, 2025.",
      "update_date": "09/19/2025",
      "therapeutic_category": [
        "Gastroenterology"
      ],
      "dosage_form": "Tablet",
      "presentation": "Ocaliva, Tablet, 5 mg (NDC 69516-005-30)",
      "company_name": "Intercept Pharmaceuticals",
      "status": "To Be Discontinued"
    }
  ]
}